Lancashire and South Cumbria Formulary Home Admin netFormulary Chapters Medicines A-Z News Mobile Reports Feedback  Search  Document Library All Pathways and Guidance | Change log | High Cost Drugs | LSC Critical Care Medicines Information | LSC ICS proxy ordering of medications in care homes | LSC Respiratory Resources | LSCMMG Consultations | LSCMMG Endorsed Secondary Care Guidelines | LSCMMG Minutes | LSCMMG Workplans | LSCMMG: About | New Medicine Reviews | PGDs | Place documents | Shared Care Guidelines | All Pathways and Guidance   Antihistamine: Position Statement  Antipsychotics: second generation long-acting injection (LAI) antipsychotics  Asthma Treatment Guidelines for Adults (Aged 17 and over)  Asthma Treatment Guidelines for Children  Atrial Fibrillation: Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease  Axial Spondyloarthritis: High Cost Drugs Commissioning Pathway  Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement  Branded Generics: Position Statement  Camouflaging Products: Position Statement  Cannabis-Based Medicinal Products: Position Statement  Colistimethate for nebulisation: Prescribing Information Sheet  Constipation: Primary Care Pathways  COPD Desktop Guideline  Degarelix: Prescribing Information Sheet  Dementia: Management of Behavioural and Psychological Symptoms of Dementia - Primary Care Summary Document  Dementia: Management of Behavioural and Psychological Symptoms of Dementia in Primary and Secondary Care  Dementia: Prescribing Information Sheet  Denosumab: Position Statement  Diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes  Diabetes: Appendix B antihyperglycaemics guideline - diabeties self management contract (Prescriber Resource)  Diabetes: Appendix B antihyperglycaemics guideline - glucagon like peptide contract (Prescriber Resource)  Diabetes: Recommended meters, strips and devices  Dosulepin: Guidelines for Primary Care  E-Cigarettes: Position Statement  Erectile Dysfunction Guideline  Eye: LSC Community Urgent Eye Service (CUES)  Fluoride High Strength Toothpastes: Position Statement  Gender dysphoria: Requests from a private GIC to prescribe hormone therapy or blockade in gender dysphoria  Generic Biosimilar Medicines: Position Statement  Gluten-Free food products: Position Statement  Good prescribing in primary care guidance document  Gout Prescribing Guidance  Headache Management Guideline For Adults  Heart Failure - Primary Care Guideline for the Use of SGLT-2 Inhibitors in Reduced Ejection Fraction Heart Failure  HidraWear: Position Statement  Hydroxychloroquine: Prescribing Information Sheet  Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement  Infant formula feeds guidance document  Inflammatory Bowel Disease​: High Cost Drugs Commissioning Pathway  Insomnia in Adults  Insulin Toujeo: Information Sheet and Good Practice Guide  Ivabradine: Prescribing Information Sheet  Juvenile Idiopathic Arthritis in adult patients: Position statement for biological agents  Levetiracetam (Keppra®) prescribing: bioequivalence and antiepileptic drugs: Position Statement  Linezolid: Prescribing Information Sheet  Lipid Management: Pathway for Primary Prevention of Cardiovascular Disease (CVD)  Lipid Management: Pathway for Secondary Prevention of Cardiovascular Disease (CVD)  Low molecular weight heparin (LMWH) prescribing guide  Melatonin Pathway (Children)  Morphine (High dose) prescribing for chronic non-cancer pain: Position Statement  Neuropathic Pain: Primary Care Management  Opioid reduction: best interests opioid reduction position statement  OpioId treatment: patient-prescriber opioid treatment agreement  Opthalmology Macular Pathways  Oral Nutritional Supplements in Primary Care  Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy  Overactive bladder in female adults  Pain: Assessing suitability for strong opioid use  Palliative Care Clinical Practice Summary See more information under chapter 21 'Palliative Care Formulary'.  PKU (Phlexy-Vit) Prescribing of multivitamins and phenylalanine-free amino acid substitutes for adults and children  Prescribing: requests from out of area  Proton pump inhibitor (PPI): Primary Care Review Pathway  Psoriasis: LSCMMG Biologic and High Cost Drug Commissioning Pathway  Psoriasis: primary care guidance document  Psoriatic Arthritis: High Cost Drugs Commissioning Pathway  Recurrent UTI Prophylactic Antibiotic Pathway  Restless Legs Syndrome in Adults in Primary Care  Rheumatoid Arthritis: High Cost Drugs Commissioning Pathway  Riluzole: Patient Information  Rimegepant position statement  Scabies operational clinical pathway  Somatropin: Prescribing Information Leaflet  Stoma and continence Products Prescription Management guide  Tapentadol MR position statement  Tirzepatide for managing overweight and obesity  Tirzepatide for Type 2 Diabetes position statement  Trans female gender dysphoria: Prescribing information sheet  Trans male gender dysphoria: Prescribing information sheet  Trans-Anal Irrigation Devices position statement  Vitamin D position statement v3.3